Moesby L, Corver J, Erukulla R K, Bittman R, Wilschut J
Department of Physiological Chemistry, Groningen Institute for Drug Studies (GIDS), University of Groningen, The Netherlands.
Biochemistry. 1995 Aug 22;34(33):10319-24. doi: 10.1021/bi00033a001.
The alphavirus Semliki Forest virus (SFV) enters cells through receptor-mediated endocytosis. Subsequently, triggered by the acid pH in endosomes, the viral envelope fuses with the endosomal membrane. Membrane fusion of SFV has been shown previously to be dependent on the presence of cholesterol in the target membrane. Recently, we have demonstrated that fusion of SFV also requires sphingolipids [Nieva, J. L., Bron, R., Corver, J., & Wilschut, J. (1994) EMBO J. 13, 2797-2804]. In the present paper, we show that the activation of low-pH-dependent fusion of SFV by sphingolipids is a stereospecific process. Pyrene-labeled SFV fused rapidly and extensively with liposomes consisting of a mixture of phosphatidylcholine, phosphatidylethanolamine, and cholesterol, supplemented with low concentrations of D-erythro-ceramide, representing the naturally occurring sphingolipid stereoisomer. Fusion was assessed by a decrease in the pyrene excimer fluorescence. L-erythro-, D-threo-, and L-threo-ceramide did not support fusion of the virus. Similar results were obtained with the corresponding sphingomyelin stereoisomers. The stereospecificity of SFV fusion activation was confirmed by using an assay based on degradation of the viral capsid protein by trypsin encapsulated in the target liposomes. Fusion mediated by D-erythro-ceramide was not affected by the additional presence in the target liposomes of ceramide stereoisomers incapable of fusion activation. Binding of the virus to the liposomes, as assessed by flotation on sucrose density gradients, was not dependent on the presence of fusion-competent or fusion-incompetent sphingolipids in the liposomes. The results of this study support the notion that a stereospecific interaction of the viral fusion protein with D-erythro sphingolipids in the target membrane represents an essential step in the activation of the fusion capacity of SFV.
甲病毒塞姆利基森林病毒(SFV)通过受体介导的内吞作用进入细胞。随后,在内体酸性pH的触发下,病毒包膜与内体膜融合。先前已证明SFV的膜融合依赖于靶膜中胆固醇的存在。最近,我们证明了SFV的融合还需要鞘脂[涅瓦,J.L.,布龙,R.,科尔弗,J.,& 威尔舒特,J.(1994年)《欧洲分子生物学组织杂志》13,2797 - 2804]。在本文中,我们表明鞘脂对SFV低pH依赖性融合的激活是一个立体特异性过程。芘标记的SFV与由磷脂酰胆碱、磷脂酰乙醇胺和胆固醇的混合物组成的脂质体迅速且广泛地融合,该脂质体补充有低浓度的D - 赤藓糖神经酰胺,代表天然存在的鞘脂立体异构体。通过芘准分子荧光的降低来评估融合。L - 赤藓糖、D - 苏阿糖和L - 苏阿糖神经酰胺不支持病毒融合。相应的鞘磷脂立体异构体也得到了类似结果。通过基于包裹在靶脂质体中的胰蛋白酶对病毒衣壳蛋白的降解的测定,证实了SFV融合激活的立体特异性。靶脂质体中额外存在不能激活融合的神经酰胺立体异构体并不影响由D - 赤藓糖神经酰胺介导的融合。通过在蔗糖密度梯度上漂浮评估,病毒与脂质体的结合不依赖于脂质体中具有融合能力或无融合能力的鞘脂的存在。本研究结果支持这样一种观点,即病毒融合蛋白与靶膜中D - 赤藓糖鞘脂的立体特异性相互作用是激活SFV融合能力的关键步骤。